Business Description
Alligator Bioscience AB
ISIN : SE0000767188
Compare
Compare
Traded in other countries / regions
ATORX.Sweden7AL.Germany0RK9.UK IPO Date
2016-11-25Description
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.87 | |||||
| Equity-to-Asset | -0.58 | |||||
| Debt-to-Equity | -0.27 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -23.83 | |||||
| Beneish M-Score | -4.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 52 | |||||
| 3-Year EBITDA Growth Rate | 22 | |||||
| 3-Year EPS without NRI Growth Rate | 23.3 | |||||
| 3-Year FCF Growth Rate | 29.1 | |||||
| 3-Year Book Growth Rate | -72.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.01 | |||||
| 9-Day RSI | 72.02 | |||||
| 14-Day RSI | 66.78 | |||||
| 6-1 Month Momentum % | 91.8 | |||||
| 12-1 Month Momentum % | 101.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.37 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.3 | |||||
| Days Sales Outstanding | 38.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -69.9 | |||||
| Shareholder Yield % | -23.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -444.47 | |||||
| Net Margin % | -448.35 | |||||
| FCF Margin % | -409.49 | |||||
| ROE % | -650.53 | |||||
| ROA % | -168.94 | |||||
| ROIC % | -189.92 | |||||
| ROC (Joel Greenblatt) % | -1083.73 | |||||
| ROCE % | -511.4 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.46 | |||||
| EV-to-EBIT | -3.46 | |||||
| EV-to-EBITDA | -3.61 | |||||
| EV-to-Revenue | 15.27 | |||||
| EV-to-FCF | -3.52 | |||||
| Earnings Yield (Greenblatt) % | -28.91 | |||||
| FCF Yield % | -25.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alligator Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.795 | ||
| EPS (TTM) (€) | -0.041 | ||
| Beta | 1.26 | ||
| Volatility % | 130.8 | ||
| 14-Day RSI | 66.78 | ||
| 14-Day ATR (€) | 0.003859 | ||
| 20-Day SMA (€) | 0.075575 | ||
| 12-1 Month Momentum % | 101.39 | ||
| 52-Week Range (€) | 0.0206 - 0.1224 | ||
| Shares Outstanding (Mil) | 758.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alligator Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alligator Bioscience AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alligator Bioscience AB Frequently Asked Questions
What is Alligator Bioscience AB(FRA:7AL)'s stock price today?
The current price of FRA:7AL is €0.09. The 52 week high of FRA:7AL is €0.12 and 52 week low is €0.02.
When is next earnings date of Alligator Bioscience AB(FRA:7AL)?
The next earnings date of Alligator Bioscience AB(FRA:7AL) is 2024-07-12 Est..
Does Alligator Bioscience AB(FRA:7AL) pay dividends? If so, how much?
Alligator Bioscience AB(FRA:7AL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers